01 May 2004 :
Safety and tolerability of the combination therapy with pegylatedinterferon alfa-2a (Pegasys®) and ribavirin (Copegus®) in patientswith chronic hepatitis C in Poland – interim analysis of data fromEAP program
Med Sci Monit 2004; 10(1): 12-16 :: ID: 11832
HTML version available soon